The Pharma Monopoly Play: What an AstraZeneca Bristol Myers Merger Means for Global Healthcare The whispers of a potential megadeal between AstraZeneca and Bristol Myers Squibb have sent shockwaves through the pharmaceutical industry, raising questions about the future of global healthcare.
According to sources close to the matter, the two companies have been exploring a merger of their operations, which would create one of the largest drugmakers in the world.
A combined entity would significantly increase market share and bolster AstraZeneca's presence in the lucrative US market.